Ke Xu

10.3k total citations · 2 hit papers
114 papers, 4.3k citations indexed

About

Ke Xu is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Ke Xu has authored 114 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 37 papers in Infectious Diseases and 24 papers in Molecular Biology. Recurrent topics in Ke Xu's work include Influenza Virus Research Studies (39 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral gastroenteritis research and epidemiology (15 papers). Ke Xu is often cited by papers focused on Influenza Virus Research Studies (39 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral gastroenteritis research and epidemiology (15 papers). Ke Xu collaborates with scholars based in China, Germany and Japan. Ke Xu's co-authors include Ke Lan, Yu Chen, Yingle Liu, Bing Sun, Qingyan Fu, Yusen Duan, Dane Westerdahl, Haidong Kan, Yuan Liu and Xinjin Liu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ke Xu

103 papers receiving 4.3k citations

Hit Papers

Aerodynamic analysis of S... 2020 2026 2022 2024 2020 2020 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ke Xu 1.7k 1.1k 1.0k 848 628 114 4.3k
Nicole M. Bouvier 1.1k 0.7× 2.2k 2.0× 1.2k 1.1× 652 0.8× 821 1.3× 45 4.4k
Yingle Liu 2.2k 1.3× 837 0.7× 1.1k 1.1× 1.7k 2.0× 992 1.6× 88 6.1k
John A. Lednicky 2.7k 1.6× 965 0.9× 1.4k 1.4× 479 0.6× 315 0.5× 195 6.6k
Seema S. Lakdawala 869 0.5× 1.3k 1.2× 1.0k 1.0× 715 0.8× 377 0.6× 65 3.2k
Atsushi Okumura 2.9k 1.8× 855 0.8× 432 0.4× 714 0.8× 1.0k 1.6× 98 5.2k
Ke Lan 2.1k 1.3× 2.1k 1.8× 1.2k 1.2× 1.9k 2.3× 897 1.4× 199 7.3k
Yang Pan 2.6k 1.5× 624 0.6× 476 0.5× 913 1.1× 719 1.1× 135 5.1k
Xiaoyan Lu 2.9k 1.8× 2.8k 2.5× 761 0.8× 864 1.0× 407 0.6× 125 5.8k
Ian M Mackay 3.0k 1.8× 3.7k 3.3× 1.2k 1.2× 1.8k 2.1× 485 0.8× 105 8.4k
Won Suk Choi 1.1k 0.7× 2.0k 1.7× 522 0.5× 536 0.6× 378 0.6× 285 4.4k

Countries citing papers authored by Ke Xu

Since Specialization
Citations

This map shows the geographic impact of Ke Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Xu more than expected).

Fields of papers citing papers by Ke Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Xu. The network helps show where Ke Xu may publish in the future.

Co-authorship network of co-authors of Ke Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Xu. A scholar is included among the top collaborators of Ke Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Xu. Ke Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Ruiqi, et al.. (2025). Insights into the role of histone lysine demethylases in bone homeostasis and skeletal diseases: A review. International Journal of Biological Macromolecules. 306(Pt 4). 141807–141807.
2.
3.
Xu, Ke, et al.. (2025). Resuspension of surface particles from the free-fall package: A chamber study. Building and Environment. 270. 112549–112549.
4.
Huang, Rong, Ke Xu, Xingyu Yang, et al.. (2025). Mitochondrial homeostasis dysfunctions during the epithelial-mesenchymal transition process in lens epithelial cells. Experimental Eye Research. 260. 110583–110583.
5.
Xu, Ke, et al.. (2025). pH‐Responsive Polyglycerol Nanogels for Periodontitis Treatment through Antibacterial and Pro‐Angiogenesis Action. Angewandte Chemie International Edition. 64(9). e202418882–e202418882. 7 indexed citations
6.
Wang, Lühua, Jing Zhou, Jingjing Chen, et al.. (2025). Microstructure and thermal conductance of the AlN-on-sapphire heterostructure prepared by metal-organic chemical vapor deposition. Vacuum. 238. 114335–114335.
7.
Xu, Ke, et al.. (2025). The Effect of Partial Sleep Deprivation on Retinal Microvasculature in Myopia With Different Axial Lengths. Investigative Ophthalmology & Visual Science. 66(3). 57–57. 1 indexed citations
8.
Wu, Yu, Zirui Zhang, Zhongyu Liu, et al.. (2024). AlGaN Based Deep Ultraviolet LED for Inactivating Coxsackie Virus. Chinese Journal of Luminescence. 45(8). 1391–1397. 1 indexed citations
9.
Xu, Ke, Yu Zhang, Yue Shi, et al.. (2024). Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis. Frontiers in Cellular Neuroscience. 18. 1464595–1464595. 3 indexed citations
10.
Dèng, Fēi, Tian Qiu, Ke Xu, et al.. (2024). Respiratory pathogen dynamics in community fever cases: Jiangsu Province, China (2023–2024). Virology Journal. 21(1). 226–226. 1 indexed citations
11.
Li, Yulei, Peipei Liu, X. L. Wang, et al.. (2024). A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants. PLoS Pathogens. 20(9). e1012508–e1012508. 2 indexed citations
12.
Liu, Qianyun, Zhen Zhang, Jiangpeng Feng, et al.. (2024). SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis. The Journal of Cell Biology. 224(1). 2 indexed citations
13.
Zheng, Yucheng, Shiliang Li, Kun Song, et al.. (2022). A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. Viruses. 14(5). 928–928. 34 indexed citations
14.
Ye, Qing, Mei Wu, Chao Zhou, et al.. (2022). Rational development of a combined mRNA vaccine against COVID-19 and influenza. npj Vaccines. 7(1). 84–84. 33 indexed citations
15.
Liu, Yuan, Zhi Ning, Yu Chen, et al.. (2020). Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 582(7813). 557–560. 1389 indexed citations breakdown →
16.
Ma, Chi, Ke Xu, Lin Xu, et al.. (2018). Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF-κB and MAPK signal pathways. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Ye, Jingrong, et al.. (2015). Construction and immunogenicity study of recombinant MVA vaccine expressing HIV-1 CRF01_AE gp145 gene.. 29(3). 263–265. 1 indexed citations
18.
Xu, Ke. (2013). A prospective cohort study on positive seroconversion of HIV and Treponema pallidum antibodies among men who have sex with men in Hangzhou. Jibing jiance. 1 indexed citations
19.
Liu, Wendong, et al.. (2013). Risk assessment on the epidemics of human infection with a novel avian influenza A (H7N9) virus in Jiangsu Province, China. Journal of Biomedical Research. 27(3). 163–163. 6 indexed citations
20.
Xu, Ke, et al.. (1990). β-AGKISTRODOTOXIN: A PRESYNAPTIC NEUROTOXIN FROM VENOM OF THE PIT VIPER (Agkistrodon blomhoffii brevicaudus STEJNEGER). 科学通报(英文版). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026